Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

Yishai Ofran; Eric Beohou; Myriam Labopin; Didier Blaise; Jan J Cornelissen; Marco R de Groot; Gerard Socié; Anne Huynh; Johan Maertens; Frederic Baron; Mohamad Mohty; Arnon Nagler

doi:10.1111/bjh.15131

Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

Br J Haematol. 2019 Feb;184(4):643-646. doi: 10.1111/bjh.15131. Epub 2018 Feb 21.

Authors

Yishai Ofran¹, Eric Beohou^{2

3

4

5}, Myriam Labopin^{2

3

4

5}, Didier Blaise⁶, Jan J Cornelissen⁷, Marco R de Groot⁸, Gerard Socié^{9

10}, Anne Huynh¹¹, Johan Maertens¹², Frederic Baron¹³, Mohamad Mohty^{2

3

4

5}, Arnon Nagler^{2

14}

Affiliations

¹ Department of Haematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² EBMT Paris Study Office/CEREST-TC, Paris, France.
³ Department of Haematology, Saint Antoine Hospital, Paris, France.
⁴ INSERM UMR 938, Paris, France.
⁵ Université Pierre et Marie Curie, Paris, France.
⁶ Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
⁷ Department of Haematology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.
⁸ Department of Haematology, University Medical Centre Groningen (UMCG), Groningen, the Netherlands.
⁹ APHP Haematology Transplantation, University Paris 7, Paris, France.
¹⁰ INSERM UMR 1160, Paris, France.
¹¹ Institut Universitaire du Cancer Toulouse, Oncopole, Toulouse, France.
¹² Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium.
¹³ GIGA-I3, University of Liege, Liege, Belgium.
¹⁴ Division of Haematology and Bone Marrow Transplantation, Chaim Sheba Medical Centre, Ramat-Gan, Israel.

PMID: 29468648
DOI: 10.1111/bjh.15131

No abstract available

Keywords: GVHD-free relapse-free survival; acute myeloid leukaemia; anti-thymocyte globulins; chronic graft-versus-host disease; reduced-intensity conditioning.

Publication types

Clinical Trial
Letter
Multicenter Study

MeSH terms

Adolescent
Adult
Aged
Antilymphocyte Serum / administration & dosage*
Bone Marrow Transplantation
Europe
Female
Graft vs Host Disease / prevention & control*
Humans
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Remission Induction*
Retrospective Studies
Societies, Medical
Stem Cell Transplantation*
Transplantation Conditioning

Substances

Antilymphocyte Serum